Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-039652
Filing Date
2009-08-31
Accepted
2009-08-31 12:32:47
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g20356e10vq.htm 10-Q 198716
2 EX-31.1 g20356exv31w1.htm EX-31.1 7301
3 EX-31.2 g20356exv31w2.htm EX-31.2 7604
4 EX-32.1 g20356exv32w1.htm EX-32.1 3837
5 GRAPHIC g20356g2035600.gif GRAPHIC 6785
  Complete submission text file 0000950123-09-039652.txt   228343
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 091045113
SIC: 2834 Pharmaceutical Preparations